BGS Pharmacy Partners will receive an initial $10 million growth capital commitment from DW Healthcare Partners.
BGS Pharmacy Partners, an alternate care pharmacy company based in Grapevine, Texas, will receive an initial $10 million growth capital commitment from DW Healthcare Partners to finance acquisitions and development.
"We wanted a partner with extensive experience and relationships in the healthcare services industry," BGS founder and CEO Robert DellaValle said. "DW Healthcare Partners' support will enable us to continue our strategy of acquiring and developing leading institutional pharmacies to better serve the hospice and long-term care markets."
For the complete story, click here.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, clickhere.